Summary & Overview
HCPCS C1832: Autograft Suspension with Cell Processing and Application
Headline: HCPCS Level II code C1832 defines autograft suspension with cell processing and system components
Lead: HCPCS Level II code C1832 covers autograft suspension services that include cell processing, application, and all related system components. This code captures a specialized, autologous tissue-processing procedure used in surgical and regenerative contexts.
What it represents and why it matters: The code identifies a bundled service for preparing and applying a patient-derived graft suspension, integrating cell-processing steps and delivery systems. Nationally, accurate use of this HCPCS Level II code affects procedural billing clarity, coverage determinations, and tracking of advanced autologous therapies as they become more common in surgical reconstruction and regenerative medicine.
Key payers covered: The analysis addresses coverage and coding implications for Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication outlines clinical context for autograft suspension procedures, typical sites of service (operating room or procedural suite), and the components captured by C1832. It presents benchmarking and policy-relevant information where available, highlights common billing considerations, and notes areas where payer-specific coverage rules or documentation requirements commonly apply. Data not available in the input will be labeled as such where relevant.
Billing Code Overview
HCPCS Level II code C1832 describes an autograft suspension service that includes cell processing and application and all system components. The service involves preparing and applying a patient-derived graft material that has undergone processing to suspend cells for therapeutic implantation.
-
Service type: Autologous graft preparation and application
-
Typical site of service: Operating room or procedural suite where surgical grafting and cell processing occur
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with a chronic full-thickness tendon defect of the Achilles tendon undergoes operative reconstruction using an autologous tissue suspension harvest and application system. The orthopedic surgical team harvests a small volume of the patient’s adipose tissue and bone-marrow aspirate in the operating room, processes the cells intraoperatively with a closed autograft suspension system, and applies the processed autologous suspension to the repair site to augment biologic healing. The procedure includes cell processing, preparation of the suspension, and delivery components integrated into the surgical workflow. Typical site of service is an ambulatory surgical center or hospital outpatient department; inpatient setting may be used if concurrent hospitalization is required. Perioperative documentation includes indication, informed consent for autologous cell processing, details of harvest site and volume, device/system used, processing steps, application method, time in surgery, and any adjunctive procedures (e.g., tendon repair, debridement). Post-procedure documentation includes immediate hemostasis, wound closure, and postoperative plan including immobilization and rehabilitation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, and effort substantially exceed usual for the autograft suspension procedure; attach documentation of why service was more complex. |